辰欣药业：第三季度净利润同比上升19.61%

Core Viewpoint - Chenxin Pharmaceutical (603367.SH) reported a decline in operating revenue for Q3 2025, while net profit showed an increase year-on-year [1] Financial Performance - The company's operating revenue for Q3 2025 was 844 million yuan, representing a year-on-year decrease of 9.41% [1] - The net profit attributable to shareholders of the listed company was 153 million yuan, reflecting a year-on-year increase of 19.61% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 94.38 million yuan, which is a year-on-year decrease of 25.58% [1]